A diabetologist‘s view on the metabolic surgery in the treatment of patients with type 2 diabetes
Authors:
Martin Haluzík
Authors place of work:
Ústav lékařské biochemie a laboratorní diagnostiky 1. LF UK a VFN v Praze
; Endokrinologický ústav, Praha
; Centrum experimentální medicíny a Centrum diabetologie, IKEM, Praha
Published in the journal:
AtheroRev 2017; 2(1): 25-31
Category:
Reviews
Summary
Surgical treatment of patients with higher degrees of obesity is an inseparable part of the treatment algorithms of this disease. Bariatric surgery is highly efficacious with high durability of its effects, good safety and enough long-term experience. Recently, the significant metabolic effects of bariatric surgery – marked improvement of metabolic complications of obesity, in particular type 2 diabetes mellitus, after some operations that are relatively independent on weight loss, are intensively discussed. These findings gave rise to term metabolic surgery that is now increasingly used worldwide in connection with surgical treatment of diabetics. This paper reviews current indications to bariatric surgery and discusses practical aspects of the preoperative preparation and postoperative follow up of diabetics after bariatric surgery. We also discuss in details the term metabolic surgery and a recently published new consensus on the use of metabolic surgery in the treatment of diabetes.
Key words:
bariatric surgery, type 2 diabetes mellitus, metabolic surgery, obesity, diabetes remission
Zdroje
1. Ashrafian H, le Roux CW, Darzi A et al. Effects of bariatric surgery on cardiovascular function. Circulation 2008; 118(20): 2091–2102. Dostupné z DOI: <http://dx.doi.org/10.1161/CIRCULATIONAHA.107.721027>.
2. Ashrafian H, Ahmed K, Rowland SP et al. Metabolic surgery and cancer: protective effects of bariatric procedures. Cancer 2011; 117(9): 1788–1799. Dostupné z DOI: <http://dx.doi.org/10.1002/cncr.25738>.
3. Rubino F, Cummings DE. Surgery: the coming of age of metabolic surgery. Nature reviews Endocrinology 2012; 8(12): 702–704. Dostupné z DOI: <http://dx.doi.org/10.1038/nrendo.2012.207>.
4. Sjostrom L, Narbro K, Sjostrom CD et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007; 357(8): 741–752.
5. O'Brien PE. Bariatric surgery: mechanisms, indications and outcomes. J Gastroenterol Hepatol 2010; 25(8): 1358–1365. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1440–1746.2010.06391.x>.
6. Pories WJ. Bariatric surgery: risks and rewards. J Clin Endocrinol Metab 2008; 93(11 Suppl 1): S89-S96. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2008–1641>.
7. Pournaras DJ, Aasheim ET, Sovik TT et al. Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders. Br J Surg 2012; 99(1): 100–103. Dostupné z DOI: <http://dx.doi.org/10.1002/bjs.7704>.
8. Pournaras DJ, Osborne A, Hawkins SC et al. Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes. Ann Surg 2010; 252(6): 966–971. Dostupné z DOI: <http://dx.doi.org/10.1097/SLA.0b013e3181efc49a>.
9. Nannipieri M, Baldi S, Mari A et al. Roux-en-Y Gastric Bypass and Sleeve Gastrectomy: Mechanisms of Diabetes Remission and Role of Gut Hormones. J Clin Endocrinol Metab 2013; 98(11): 4391–4399. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2013–2538>.
10. Woelnerhanssen B, Peterli R, Steinert RE et al. Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy-a prospective randomized trial. Surg Obes Relat Dis 2011; 7(5): 561–568. Dostupné z DOI: <http://dx.doi.org/10.1016/j.soard.2011.01.044>.
11. Haluzikova D, Lacinova Z, Kavalkova P et al. Laparoscopic sleeve gastrectomy differentially affects serum concentrations of FGF-19 and FGF-21 in morbidly obese subjects. Obesity (Silver Spring) 2013; 21(7): 1335–1342. Dostupné z DOI: <http://dx.doi.org/10.1002/oby.20208>.
12. Haluzik M. Bariatric surgery and the mechanism of diabetes remission: are we getting there? J Clin Endocrinol Metab 2013; 98(11): 4336–4338. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2013–3698>.
13. Camastra S, Gastaldelli A, Mari A et al. Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes. Diabetologia 2011; 54(8): 2093–2102. Dostupné z DOI: <http://dx.doi.org/10.1007/s00125–011–2193–6>.
14. Fried M, Yumuk V, Oppert JM et al. Interdisciplinary European guidelines on metabolic and bariatric surgery. Obes Surg 2014; 24(1): 42–55. Dostupné z DOI: <http://dx.doi.org/10.1007/s11695–013–1079–8>.
15. Bueter M, Ahmed A, Ashrafian H et al. Bariatric surgery and hypertension. Surg Obes Relat Dis 2009; 5(5): 615–620. Dostupné z DOI: <http://dx.doi.org/10.1016/j.soard.2009.03.218>.
16. Dixon JB, le Roux CW, Rubino F et al. Bariatric surgery for type 2 diabetes. Lancet 2012; 379(9833): 2300–2311. Dostupné z DOI: <http://dx.doi.org/10.1016/S0140–6736(12)60401–2>.
17. Pournaras DJ, Aasheim ET, Bueter M et al. Effect of bypassing the proximal gut on gut hormones involved with glycemic control and weight loss. Surg Obes Relat Dis 2012; 8(4): 371–374. Dostupné z DOI: <http://dx.doi.org/10.1016/j.soard.2012.01.021>.
18. Cummings DE, Weigle DS, Frayo RS et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002; 346(21): 1623–1630.
19. Bradnova O, Kyrou I, Hainer V et al. Laparoscopic greater curvature plication in morbidly obese women with type 2 diabetes: effects on glucose homeostasis, postprandial triglyceridemia and selected gut hormones. Obes Surg 2014; 24(5): 718–726. Dostupné z DOI: <http://dx.doi.org/10.1007/s11695–013–1143–4>.
20. Schauer PR, Bhatt DL, Kashyap SR. Bariatric surgery versus intensive medical therapy for diabetes. N Engl J Med 2014; 371(7): 682. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMc1407393>.
21. Schauer PR, Bhatt DL, Kirwan JP et al. Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes. N Engl J Med 2014; 370(21): 2002–2013.Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa1401329>.
22. Schauer PR, Kashyap SR, Wolski K et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012; 366(17): 1567–1576. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa1200225
23. Ashrafian H, Bueter M, Ahmed K et al. Metabolic surgery: an evolution through bariatric animal models. Obes Rev 2010; 11(12): 907–920. Dostupné z DOI: 24. Ashrafian H, le Roux CW. Metabolic surgery and gut hormones – a review of bariatric entero-humoral modulation. Physiol Behav 2009; 97(5): 620–631. Dostupné z DOI: <http://dx.doi.org/10.1016/j.physbeh.2009.03.012>.
25. Bal BS, Finelli FC, Koch TR. Origins of and recognition of micronutrient deficiencies after gastric bypass surgery. Curr Diab Rep 2011; 11(2): 136–141. Dostupné z DOI: <http://dx.doi.org/10.1007/s11892–010–0169–4>.
26. Rubino F, Nathan DM, Eckel RH et al. Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations. Diabetes Care 2016; 39(6): 861–877. Dostupné z DOI: <http://dx.doi.org/10.2337/dc16–0236>.
27. Patel SR, Mason J, Hakim N. The Duodenal-Jejunal Bypass Sleeve (EndoBarrier Gastrointestinal Liner) for Weight Loss and Treatment of Type II Diabetes. Indian J Surg 2012; 74(4): 275–277. Dostupné z DOI: <http://dx.doi.org/10.1007/s12262–012–0721–3>.
28. Kavalkova P, Mraz M, Trachta P et al. Endocrine effects of duodenal-jejunal exclusion in obese patients with type 2 diabetes mellitus. J Endocrinol 2016; 231(1): 11–22. Dostupné z DOI: <http://dx.doi.org/10.1530/JOE-16–0206>.
29. Sucharda P, Stránská Z. Metabolická chirurgie: definice, indikace, příprava a sledování pacientů internistou. In: Haluzík et al. Praktická léčba diabetu. 2. vyd. Mladá fronta: Praha 2013: 117–128. ISBN 978–80–204–2880–6.
Štítky
Angiology Diabetology Internal medicine Cardiology General practitioner for adultsČlánok vyšiel v časopise
Athero Review
2017 Číslo 1
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Memantine Eases Daily Life for Patients and Caregivers
- Spasmolytic Effect of Metamizole
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
Najčítanejšie v tomto čísle
- Adherence to treatment – an important part of reaching therapeutic effects on chronic conditions
- The review of drug interactions and risks of statin therapy
- Adherence to treatment according to the psychologist
- A diabetologist‘s view on the metabolic surgery in the treatment of patients with type 2 diabetes